🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The primary objective of this study is to determine the effects of semaglut...
Status
Recruiting
Location
University of Colorado Anschutz Medical Campus
Start Date
2024-04-05
Trial ID
NCT05822609
Treatments Being Tested
The hypothesis for this study is that the GLP-1Ra Semaglutide has a positiv...
Status
Unknown
Location
Odense University Hospital
Start Date
2021-03-24
Trial ID
NCT04702516
This study looks into how the type 2 diabetes medicine, semaglutide, can pr...
Status
Completed
Location
Clinical Trials Unit / Center for Medical Research
Start Date
2019-08-12
Trial ID
NCT04032197
Treatments Being Tested
This trial is conducted in Asia, Europe and North America. The aim of the t...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2017-03-15
Trial ID
NCT03086330
Treatments Being Tested
This study is done to find out whether the medicine, semaglutide, has a pos...
Status
Completed
Location
Banner Alzheimer's Institute
Start Date
2021-05-18
Trial ID
NCT04777396
Treatments Being Tested
The goal of this clinical trial is to learn if semaglutide can reduce illic...
Status
Recruiting
Location
University of Maryland Baltimore
Start Date
2025-01-13
Trial ID
NCT06548490
Treatments Being Tested
The purpose of the study is to explore the effects of GLP-1 receptor agonis...
Status
Completed
Location
UMC Ljubljana
Start Date
2019-11-02
Trial ID
NCT04263415
Treatments Being Tested
The goal of this clinical study is to understand whether the study drugs, s...
Status
Completed
Location
University of Alabama at Birmingham Hospital
Start Date
2021-08-09
Trial ID
NCT04971785
Treatments Being Tested
This study will look at the change in participants' body weight from the st...
Status
Completed
Location
Novo Nordisk Investigational Site
Start Date
2019-01-21
Trial ID
NCT03811574
Treatments Being Tested
This study will look at how much CagriSema helps participants with type 2 d...
Status
Completed
Location
Nat Res Inst Huntington Park
Start Date
2024-03-19
Trial ID
NCT06323174
Treatments Being Tested